While providers would be relieved of their administrative burden, standardizing care pathways across health plans may not be an easy task, Blase Polite, MD, MPP, explains.
Surabhi Dangi-Garimella, PhD, asked what might be the administrative burdens for physicians as they try to adopt pathways that are not as standardized or different pathways prescribed by each health plan.
Blase Polite, MD, MPP, acknowledged that incorporating certain pathways into clinics can be a clunky process. He explained that a few of the US oncology practices have used pathways for 10-15 years, and this simplifies things as pathways can help make the choice of chemotherapy that is administered. For those practices that use pathways as a standalone, there have been some extra administrative burdens, and oncologists have been frustrated with the electronic health record.
As for adopting individual pathways for different providers, Dr Polite said that that situation would face considerable blowback from the oncology community; 1 single pathway would be simpler, and in order to unify, there would be need for consensus amongst payers, providers, and pharma. “[I]f it’s going to be some quasi-governmental deeming process like we do with clinical data registries you need to have buy-in from all the stakeholders.” explained Dr Polite. Without them, the process would be much more difficult.
Despite predicting some issues and disagreements, however, Dr Polite believes that consensus can be reached without great difficulty.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More